However, we suggest that the immunosuppressive capacity of the regulatory population of FoxP3-expressing lymphocytes may be important in CRC to control continuous and aggressive inflammatory responses that may favor tumor proliferation [52,53]. The gene discussed is FOXP3; the disease is colorectal carcinoma.